Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Deonarain

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Cell Biophysics|January 1, 1994
Deoxyribonuclease I (DNAse I). A novel approach for targeted cancer therapyH Linardou, M P Deonarain, R A Spooner, et al.
Proceedings. Biological Sciences|December 22, 1990
Active site complementation in engineered heterodimers of Escherichia coli glutathione reductase created in vivoN S Scrutton, A Berry, M P Deonarain, et al.
Biochemistry|December 12, 1989
Alternative proton donors/acceptors in the catalytic mechanism of the glutathione reductase of Escherichia coli: the role of histidine-439 and tyrosine-99M P Deonarain, A Berry, N S Scrutton, et al.
Proceedings. Biological Sciences|September 22, 1990
Directed mutagenesis of the redox-active disulphide bridge in glutathione reductase from Escherichia coliM P Deonarain, N S Scrutton, A Berry, et al.
Science (New York, N.Y.)|November 13, 1992
Cooperativity induced by a single mutation at the subunit interface of a dimeric enzyme: glutathione reductaseN S Scrutton, M P Deonarain, A Berry, et al.
Protein Engineering|January 1, 1997
Redesigned anti-human placental alkaline phosphatase single-chain Fv: soluble expression, characterization and in vivo tumour targetingM P Deonarain, G Rowlinson-Busza, A J George, et al.
British Journal of Cancer|November 3, 2005
Characterisation and internalisation of recombinant humanised HMFG-1 antibodies against MUC1L M Pericleous, J Richards, A A Epenetos, et al.
Human Pathology|June 1, 1994
Genetically engineered antibodies for diagnostic pathologyR A Spooner, S Murray, G Rowlinson-Busza, et al.
Bioconjugate Chemistry|May 1, 2009
Site-specific polysialylation of an antitumor single-chain Fv fragmentA Constantinou, A A Epenetos, D Hreczuk-Hirst, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1995
Construction, expression and characterisation of a single chain anti-tumour antibody (scFv)-IL-2 fusion proteinE Boleti, M P Deonarain, R A Spooner, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Cell Biophysics|January 1, 1994
Deoxyribonuclease I (DNAse I). A novel approach for targeted cancer therapyH Linardou, M P Deonarain, R A Spooner, et al.
Proceedings. Biological Sciences|December 22, 1990
Active site complementation in engineered heterodimers of Escherichia coli glutathione reductase created in vivoN S Scrutton, A Berry, M P Deonarain, et al.
Biochemistry|December 12, 1989
Alternative proton donors/acceptors in the catalytic mechanism of the glutathione reductase of Escherichia coli: the role of histidine-439 and tyrosine-99M P Deonarain, A Berry, N S Scrutton, et al.
Proceedings. Biological Sciences|September 22, 1990
Directed mutagenesis of the redox-active disulphide bridge in glutathione reductase from Escherichia coliM P Deonarain, N S Scrutton, A Berry, et al.
Science (New York, N.Y.)|November 13, 1992
Cooperativity induced by a single mutation at the subunit interface of a dimeric enzyme: glutathione reductaseN S Scrutton, M P Deonarain, A Berry, et al.
Protein Engineering|January 1, 1997
Redesigned anti-human placental alkaline phosphatase single-chain Fv: soluble expression, characterization and in vivo tumour targetingM P Deonarain, G Rowlinson-Busza, A J George, et al.
British Journal of Cancer|November 3, 2005
Characterisation and internalisation of recombinant humanised HMFG-1 antibodies against MUC1L M Pericleous, J Richards, A A Epenetos, et al.
Human Pathology|June 1, 1994
Genetically engineered antibodies for diagnostic pathologyR A Spooner, S Murray, G Rowlinson-Busza, et al.
Bioconjugate Chemistry|May 1, 2009
Site-specific polysialylation of an antitumor single-chain Fv fragmentA Constantinou, A A Epenetos, D Hreczuk-Hirst, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1995
Construction, expression and characterisation of a single chain anti-tumour antibody (scFv)-IL-2 fusion proteinE Boleti, M P Deonarain, R A Spooner, et al.
Pageof 3